ArticleClinical and translational medicine2025

Integrative snRNA-seq, molecular docking and dynamics simulations identifies Lasmiditan as drug candidate for Alzheimer's disease.

Martin Nwadiugwu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.